CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- Open-market buys, last 90 days
- $15,026
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$15,026. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-18 | ZEN Wei Peu Director | Purchase · Convertible Promissory Note dated 2023-01-18 | +2,000,000 | $0.50 | $1.0M | 2,000,000 |
| 2023-01-12 | LEE WILLIS C COO | Grant or award · Options | +500,000 | $4.50 | $2.3M | 500,000 |
| 2023-01-12 | Zwicker Ian Harvey Director | Grant or award · Options | +100,000 | $4.50 | $450K | 100,000 |
| 2023-01-12 | ZEN Wei Peu Director | Grant or award · Options | +100,000 | $4.50 | $450K | 100,000 |
| 2023-01-12 | Lim Seah H. Director | Grant or award · Options | +100,000 | $4.50 | $450K | 100,000 |
| 2023-01-12 | Stark Charles William SVP, Clinical Development | Grant or award · Options | +100,000 | $4.50 | $450K | 100,000 |
| 2023-01-12 | Sekulich George CIO & SVP | Grant or award · Options | +100,000 | $4.50 | $450K | 100,000 |
| 2023-01-12 | NAGASAKI YASUSHI CFO | Grant or award · Options | +150,000 | $4.50 | $675K | 150,000 |
| 2023-01-12 | LEE WILLIS C COO | Grant or award · Options | +750,000 | $4.50 | $3.4M | 750,000 |
| 2023-01-12 | Niihara Yutaka Chairman and CEO | Grant or award · Warrants (right to buy) | +7,500,000 | $4.50 | $33.8M | 0 |
| 2022-11-30 | Niihara Yutaka Chairman and CEO | Purchase | +22,900 | $0.41 | $9K | 12,040,857 |
| 2022-11-29 | Niihara Yutaka Chairman and CEO | Purchase | +14,700 | $0.38 | $6K | 12,017,957 |
| 2022-11-28 | Niihara Yutaka Chairman and CEO | Purchase | +5,000 | $0.35 | $2K | 12,003,257 |
| 2022-11-04 | Niihara Yutaka Chairman and CEO | Purchase | +7,500 | $0.45 | $3K | 11,998,257 |
| 2022-11-03 | Niihara Yutaka Chairman and CEO | Purchase | +2,500 | $0.45 | $1K | 11,990,757 |
| 2022-11-02 | Niihara Yutaka Chairman and CEO | Purchase | +15,000 | $0.43 | $6K | 11,988,257 |
| 2022-11-01 | Niihara Yutaka Chairman and CEO | Purchase | +5,000 | $0.43 | $2K | 11,973,257 |
| 2022-10-31 | Niihara Yutaka Chairman and CEO | Purchase | +7,500 | $0.45 | $3K | 11,968,257 |
| 2022-10-28 | Niihara Yutaka Chairman and CEO | Purchase | +7,500 | $0.42 | $3K | 11,960,757 |
| 2022-10-27 | Niihara Yutaka Chairman and CEO | Purchase | +22,500 | $0.27 | $6K | 11,953,257 |
Page 3 of 45 · 886 trades